How might the metaverse and web3 technologies impact Cognizant's business?

May 13, 2021 ... Cathepsin H (CTSH) is a type 1 diabetes (T1D) risk gene; large-scale genetic and epidemiological studies found that T1D genetic risk ... Cognizant Earnings: Digital Transformation Demand Drives Guidance Raise; Fair Value Remains at $84 ... Narrow-moat Cognizant delivered strong first-quarter ... The company posted an adjusted EPS of $1.25, surpassing Wall Street estimates of $1.14 and reflecting a 7.8% year-over-year increase. Revenue reached $5.04 ... Mar 19, 2025 ... CTSH touched its two-year high of $90.82 on Feb. 14 and is currently trading 12.4% below that peak. CTSH stock has gained 1.7% over the three ... The Element i+™ immunodiagnostic analyzer supports diagnostic needs with total T4, cortisol, progesterone, cTSH, cCRP, and the Nu.Q® cancer test. CTSH means that all non-originating materials used in the production of the good have undergone a change in tariff classification at the 6-digit level. Cognizant Technology Solutions Stock Analysis: Historical quarterly revenues per share for Cognizant Technology Solutions and historical quarterly revenue ... Feb 15, 2019 ... Cognizant Technology Solutions Corporation has agreed to pay $25 million to settle charges that it violated the Foreign Corrupt Practices Act ( ... How much dividend does Cognizant Technology Solutions Corp pay? Within the last 12 months, Cognizant Technology Solutions Corp paid a dividend of $1.21. For the ... Cognizant offers end-to-end services covering business and technology consulting, planning and implementation, quality assurance, application value management, ...